Skip to main content
Fig. 1 | AIDS Research and Therapy

Fig. 1

From: Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses

Fig. 1

a Schematic drawing of the wild-type VSV genome (VSV wild-type), the VSV genome lacking the G protein (VSV∆G) and the recombinant form of the genome with the Ebola GP inserted in place of VSV G (VSV∆G/EBOVGP), along with an illustration depicting the rVSV∆G/EBOVGP vaccine vector. b Schematic drawing of the recombinant VSV genome with an HIV Env gene inserted in place of the VSV G protein, along with an illustration depicting the VSV∆G/HIVenv vaccine vector

Back to article page